Invited speaker
Dr. Alain Wuethrich
Dr. Alain Wuethrich
Dr. Alain Wuethrich
NHMRC Emerging Leadership Fellow/ARC DECRA Fellow, UQ
BIOGRAPHY FOR ALAIN
Dr. Alain Wuethrich
Dr. Alain Wuethrich
Dr Alain Wuethrich is a NHMRC Emerging Leadership fellow and DECRA awardee at the Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, the University of Queensland (UQ). Alain obtained his PhD in Chemistry in 2016 from the University of Tasmania, after which he joined UQ as a Swiss National Sci
Dr Alain Wuethrich is a NHMRC Emerging Leadership fellow and DECRA awardee at the Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, the University of Queensland (UQ). Alain obtained his PhD in Chemistry in 2016 from the University of Tasmania, after which he joined UQ as a Swiss National Science Foundation fellow under the mentorship of Prof Matt Trau. His multidisciplinary research develops diagnostic tools that harness nanotechnology and microfluidics to deliver patient-specific molecular profiles for precision medicine. Currently, his research focuses on the development of highly sensitive and multiplexed systems to study extracellular vesicles in cancer, detect immune toxicities in cancer and infectious diseases, and monitor aberrant protein phosphorylation in lung cancer.
Abstract
Dr. Alain Wuethrich
Abstract
Precision medicine is regarded as one of the most promising approaches to treat or even cure many severe diseases including cancer. Although precision medicine has delivered new and individualised treatment plans such as targeted therapy or immune checkpoint therapy, it has not yet lived up to its full promise. One reason that has limited
Precision medicine is regarded as one of the most promising approaches to treat or even cure many severe diseases including cancer. Although precision medicine has delivered new and individualised treatment plans such as targeted therapy or immune checkpoint therapy, it has not yet lived up to its full promise. One reason that has limited the advancement of precision medicine is the requirement for a specific molecular profile to tailor the therapy. The creation of such a molecular profile is difficult and requires highly sensitive and specific technologies that can detect accurately multiple biomarkers in readily accessible biofluids. Nanomaterial- and nanostructured-based systems have attracted interest due to their unique physico-chemical properties that can be explored as nanodiagnostics for molecular profiling in precision medicine.
This presentation will highlight examples of nanodiagnostics for:
(1) Monitoring targeted therapy in melanoma
(2) Early detection of melanoma
(3) Tracking drug-induced epithelial–mesenchymal transition in breast cancer
(4) Monitoring the immune system with single cytokine resolution
sponsors
inudstry sponsors
Add a description about this category
MILTENYI BIOTEC
Representative:
Dr Ashwin Kumar Giddam
Technical Sales Consultant (QLD)
Ph: 0405 399 949
ROWE SCIENTIFIC
IN VITRO TECHNOLOGIES
Representative:
Andrew Lowry
Equipment Specialist QLD/NT
Ph: 0407 151 850
VAXXAS
Representative:
Dr Angus Forster
Chief Development and Operations Officer
Ph: 07 3443 7838
BRUKER
Representative:
Stephen Wilson
Life Sciences Mass Spectrometry Australia/New Zealand
Ph: 0436 668 696
SCOPE SCIENTIFIC
Representative:
Paul Pearce
Microscopy Sales Specialist
Ph: 0401 278 860
JOHN MORRIS GROUP
Representative:
Paul Vranich
Sales Manager
Ph: 0412 532 485
Eppendorf
Representative:
Kerry Anderson
Sales Specialist - Queensland
Ph: 0411 268 456
ORGANISING COMMITTEE
Dr Miaomiao Liu
Dr Belinda De Villers
Dr Andrew Rayfield
Lecturer
Griffith Institute for Drug Discovery
Dr Andrew Rayfield
Dr Belinda De Villers
Dr Andrew Rayfield
Research Fellow
Griffith Institute for Drug Discovery/Menzies Health Institute Queensland
Dr Belinda De Villers
Dr Belinda De Villers
Dr Belinda De Villers
Research Fellow
Institute for Glycomics
Dr Sharareh Eskandari
Dr Belinda De Villers
Dr Belinda De Villers
Research Fellow
Institute for Glycomics
Dr Hoang-Phuong Phan
Dr Hoang-Phuong Phan
Dr Hoang-Phuong Phan
Research Fellow
Queensland Micro & Nanotechnology Centre
Dr Xiang Liu
Dr Hoang-Phuong Phan
Dr Hoang-Phuong Phan
Research Fellow
Menzies Health Institute Queensland